Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Lazertinib
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Lazertinib Lazcluze
®
(240 mg film-coated tablets)
Malignant disease and immunosuppression, Other antineoplastic drugs, 08.01.05
Links found
NICE TA1122: Amivantamab with lazertinib for untreated EGFR mutation-positive advanced non-small-cell lung cancer